Recent News
Neuroendocrine Cancer UK: PERT UPDATE 30th May 2024
As you may be aware, over the last few months, we at Neuroendocrine Cancer UK, have been working with charity partners to address the urgent need to resolve the persistent shortage of PERT (Pancreatic Enzyme Replacement Therapy) medications: Creon®, Nutrizym® 22 and...
SIRT Therapy for Neuroendocrine Tumours Webi-Natter Event – May 30th
- Neuroendocrine Cancer UK is thrilled to announce an upcoming Webi-Natter event focused on the recent news of NICE's approval of SIRT Therapy for neuroendocrine tumours. Scheduled for May 30th from 6:00pm to 7:30pm (GMT), this event will delve into the implications...
Launch of Rareminds Wellbeing Hub and Rare Minds Matter Survey Results
- Launch of Rareminds Wellbeing Hub and Release of "Rare Minds Matter - Rare Disease and Mental Health 2023 Survey Results" We are thrilled to announce the launch of the Rareminds Wellbeing Hub, a vital resource designed to help individuals navigate some of the more...